September 2026Real-world outcomes of acute myeloid leukemia patients undergoing treatment with tyrosine kinase inhibitor (TKI) therapy targeting FLT3, IDH1, or IDH2Real-World EvidencePublication summaryPublicationsAcute myeloid leukemia
August 2026Recommendations for generating real-world evidence with regulatory-grade relevance and reliabilityReal-World EvidencePublication summaryPublicationsRegulatory